Cited by 197Adipokines, Inflammation, and Metabolic DiseasesDiet, Metabolism, and DiseaseDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 299 of the 307 references it cites were found in a registry or an index; none of the 191 sources its claims cite is checked for support yet.

Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome

Open access
Paniagua, Juan Antonio·2016·World Journal of Diabetes

Abstract

Obesity is an excessive accumulation of body fat that may be harmful to health. Today, obesity is a major public health problem, affecting in greater or lesser proportion all demographic groups. Obesity is estimated by body mass index (BMI) in a clinical setting, but BMI reports neither body composition nor the location of excess body fat. Deaths from cardiovascular diseases, cancer and diabetes accounted for approximately 65% of all deaths, and adiposity and mainly abdominal adiposity are associated with all these disorders. Adipose tissue could expand to inflexibility levels. Then, adiposity is associated with a state of low-grade chronic inflammation, with increased tumor necrosis factor-α and interleukin-6 release, which interfere with adipose cell differentiation, and the action pattern of adiponectin and leptin until the adipose tissue begins to be dysfunctional. In this state the subject presents insulin resistance and hyperinsulinemia, probably the first step of a dysfunctional metabolic system. Subsequent to central obesity, insulin resistance, hyperglycemia, hypertriglyceridemia, hypoalphalipoproteinemia, hypertension and fatty liver are grouped in the so-called metabolic syndrome (MetS). In subjects with MetS an energy balance is critical to maintain a healthy body weight, mainly limiting the intake of high energy density foods (fat). However, high-carbohydrate rich (CHO) diets increase postprandial peaks of insulin and glucose. Triglyceride-rich lipoproteins are also increased, which interferes with reverse cholesterol transport lowering high-density lipoprotein cholesterol. In addition, CHO-rich diets could move fat from peripheral to central deposits and reduce adiponectin activity in peripheral adipose tissue. All these are improved with monounsaturated fatty acid-rich diets. Lastly, increased portions of ω-3 and ω-6 fatty acids also decrease triglyceride levels, and complement the healthy diet that is recommended in patients with MetS.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review argues that central obesity, dysfunctional adipose tissue, insulin resistance, and dietary macronutrient quality jointly determine the components of metabolic syndrome (MetS). It synthesizes evidence that MUFA-rich, low-GI/high-fiber, and long-chain n-3 PUFA diets improve insulin sensitivity, lipids, adipokines, and MetS prevalence.

Key findings

  • Adipose tissue dysfunction links central obesity to MetS: low-grade inflammation with increased TNF-α and IL-6, decreased adiponectin, increased leptin/leptin resistance, ectopic fat/lipotoxicity, and insulin resistance/hyperinsulinemia; MetS clusters central obesity, hyperglycemia, hypertriglyceridemia, hypoalphalipoproteinemia, hypertension, and fatty liver.
  • High-carbohydrate diets increase postprandial insulin and glucose, raise triglyceride-rich lipoproteins, lower HDL-C (approximately 11% in one cited study), shift fat centrally, and reduce adiponectin; MUFA-rich diets improve insulin sensitivity, postprandial glucose/insulin, GLP-1, and HDL-C. In LIPGENE, an LFHCC n-3 diet reduced MetS prevalence by 20.5% vs HSFA (10.6%), HMUFA (12%), or LFHCC (10.4%) diets.
  • Fiber and omega-3 effects: the ADA recommends 20-35 g/d dietary fiber; higher soluble fiber improves glycemic control, hyperinsulinemia, and plasma lipids in type 2 diabetes. Adiponectin may increase by 14%-60% with seafood/omega-3, 18%-48% with weight loss plus activity, and 60%-115% with fiber supplementation.
  • Epidemiology: MetS prevalence rose from 28% (NHANES 1988-1994) to 32% (NHANES 1999-2000); it is estimated at 11% of men and 18% of women aged 20-39, rising to 40% of men and 46% of women older than 60. Deaths from CVD, cancer, and diabetes accounted for approximately 65% of all deaths; obesity may account for up to 14% of cancer in men and 20% in women, and BMI ≥ 40 kg/m² increases cancer death risk by 52% in men and 62% in women.

Methods

  • Narrative review; no systematic search strategy, inclusion/exclusion criteria, or meta-analytic methods are stated. It synthesizes mechanistic, epidemiological, and clinical trial literature on obesity, adipose tissue, insulin resistance, MetS, and nutrition.
  • Cites specific human intervention studies, including KANWU (162 healthy subjects, 3 mo, SAFA vs MUFA diets), LIPGENE (MetS subjects n = 472 from 8 European countries, 12 wk, four diets), and small postprandial/gene-expression studies (e.g., 11 insulin-resistant subjects; NAFLD n = 9). No new primary data collection is described beyond summarizing prior work.

Limitations

  • Stated in the paper: epidemiological evidence on fat amount/type and weight gain is contradictory; residual confounding (e.g., cholesterol-lowering therapy, trans fat intake, limited variation in SFA and PUFA intake) may explain findings. Intervention studies on GI/GL have not had clarifying results, and more specific dietary fat modifications may be necessary, perhaps with dietary restriction and weight loss.
  • Evident from the text: this is a narrative review without systematic methods or formal risk-of-bias assessment; conclusions rely on heterogeneous cited studies, some very small (n = 9-15) and mechanistic, so causal inference from observational associations is limited.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.4239/wjd.v7.i19.483

Cites

299 of 299 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Thermogenesis brown adipose tissue (Bat) mediated. A: Adipocytes were developed because non adipocytes cells are unable to store calories as fat to meet fuel needs during long periods without eating. If the energy intake is more than energy expenditure, WAT is expanded and leads to obesity. However, a second type of adipose tissue, called BAT was developed especially for energy expenditure (thermogenesis). Today, research in identifying the main genes that control differentiation, development and activation of BAT is highly active, because, activation of BAT, in detriment of WAT, could have anti-obesity effects, which can be utilized to keep the system of fat deposit balanced. In this research, PRDM16, PPAR-γ and PGC-1α, have been identified as the key nodes in the regulation of inducible BAT; B: The thermogenic potential of BAT is controlled by the SNS, which densely innervates brown fat depots. In addition, BAT is activated in response to cold temperatures, hormones and possibly diet. BAT content and activation is highest in children and decreases with age. BAT activation is decreased in fatness, and BAT activity has been inversely correlated to BMI, body fat, and visceral obesity. In humans, BAT amount and activation is higher in women than in men. Of clinical relevance, BAT activation is very low in diabetic patients in comparison with non-diabetic subjects. Thyroid hormones play a main role in control of BAT activation, therefore the cold-induced enhancement of the enzyme 5’-deiodinase type II activity, which deiodinates thyroxine (T4) to T3. Catecholamines such as norepinephrine binds to β-ARs and induce PGC1α through p38 MAPK and finally triggers expression of UCP1. Whereas β1-AR is considered important for proliferation of classical brown adipocyte precursors in response to norepinephrine, β3-AR plays a major role in thermogenic function of mature brown adipocytes. Another signal, Irisin hormone which comes from muscle to fat tissue, is able to induce a robust browning programme, and mediates the beneficial effects of exercise and could reduce diet-induced obesity and insulin resistance. A more generalized program in the control of adipose tissue is conducted by FGF21 through regulating lipolysis in WAT as well as increasing substrate utilization by increasing fatty acid oxidation in the liver. Last, beige fat cell functions include either a like to “WAT” when energy balance is exceeded, or a like to “BAT” in response to many stimuli similar to BAT activation. WAT: White adipose tissue; BAT: Brown adipose tissue; PRDM16: PR domain containing 16; PPAR-γ: Peroxisome proliferator-activated receptor-γ; PGC-1α: Peroxisome proliferator-activated receptor γ coactivator 1α; SNS: Sympathetic nervous system; BMI: Body mass index; FGF21: Fibroblast growth factor 21.
Figure 1 Thermogenesis brown adipose tissue (Bat) mediated. A: Adipocytes were developed because non adipocytes cells are unable to store calories as fat to meet fuel needs during long periods without eating. If the energy intake is more than energy expenditure, WAT is expanded and leads to obesity. However, a second type of adipose tissue, called BAT was developed especially for energy expenditure (thermogenesis). Today, research in identifying the main genes that control differentiation, development and activation of BAT is highly active, because, activation of BAT, in detriment of WAT, could have anti-obesity effects, which can be utilized to keep the system of fat deposit balanced. In this research, PRDM16, PPAR-γ and PGC-1α, have been identified as the key nodes in the regulation of inducible BAT; B: The thermogenic potential of BAT is controlled by the SNS, which densely innervates brown fat depots. In addition, BAT is activated in response to cold temperatures, hormones and possibly diet. BAT content and activation is highest in children and decreases with age. BAT activation is decreased in fatness, and BAT activity has been inversely correlated to BMI, body fat, and visceral obesity. In humans, BAT amount and activation is higher in women than in men. Of clinical relevance, BAT activation is very low in diabetic patients in comparison with non-diabetic subjects. Thyroid hormones play a main role in control of BAT activation, therefore the cold-induced enhancement of the enzyme 5’-deiodinase type II activity, which deiodinates thyroxine (T4) to T3. Catecholamines such as norepinephrine binds to β-ARs and induce PGC1α through p38 MAPK and finally triggers expression of UCP1. Whereas β1-AR is considered important for proliferation of classical brown adipocyte precursors in response to norepinephrine, β3-AR plays a major role in thermogenic function of mature brown adipocytes. Another signal, Irisin hormone which comes from muscle to fat tissue, is able to induce a robust browning programme, and mediates the beneficial effects of exercise and could reduce diet-induced obesity and insulin resistance. A more generalized program in the control of adipose tissue is conducted by FGF21 through regulating lipolysis in WAT as well as increasing substrate utilization by increasing fatty acid oxidation in the liver. Last, beige fat cell functions include either a like to “WAT” when energy balance is exceeded, or a like to “BAT” in response to many stimuli similar to BAT activation. WAT: White adipose tissue; BAT: Brown adipose tissue; PRDM16: PR domain containing 16; PPAR-γ: Peroxisome proliferator-activated receptor-γ; PGC-1α: Peroxisome proliferator-activated receptor γ coactivator 1α; SNS: Sympathetic nervous system; BMI: Body mass index; FGF21: Fibroblast growth factor 21.CC BY-NC · PubMed Central
Figure 2 Dysfunctional adipose tissue. Early central obesity is associated with a low-grade chronic inflammatory state characterized by slow infiltration of macrophages which are an important source of inflammation of this adipose tissue[275,276]. Several macrophage subtypes can be found, and simply put, are divided in pro-inflammatory M1 or alternatively activated M2, although in vivo studies reveal a spectrum of macrophage phenotypes[277]. Adipocytes and immune cells such as T cells and macrophages participate in the activation and production of inflammatory cytokines[170,275,278,279]. The M1 macrophages mainly found in obesity, are induced from precursor M0 macrophages by stimulation of components of bacteria (lipopolysaccharide) and type 1 T-helper (Th1) inflammatory cytokines like IFN-γ and TNF-α. The M2 macrophages are activated by type 2 (Th2) cytokines such as IL-4 and IL-13. The M2 macrophages are abundant in adipose tissue of lean subjects and appear to be involved in remodeling, tissue repair, and maintenance of insulin sensitivity through the production and expression of IL-10, IL-1 receptor antagonist, and arginase-1. Whereas M1 macrophages use glucose for energy, M2 macrophages activate the β-oxidation of fatty acids[277,280]. Finally, M1 macrophages are the major source of inflammatory cytokines including TNF-α which inhibits adipose cell differentiation by activating Wnt signaling and suppressing expression of PPAR-γ transcription factor essential for the development and function of adipocyte, and reducing the effect on stored triglycerides[281,282]. The subcutaneous adipose tissue will continue to expand to an equilibrium point. When this capacity is exceeded, glucose and lipid uptake begins to decline and insulin levels are raised to maintain serum glucose in the normal range[215]. In addition, when WAT is unable to expand (inflexibility), associated with insulin resistance state, a continuous release of FFA to interstice begins, generating a systemic lipotoxic effect in muscle, liver, etc., (lipotoxicity). The adipose tissue itself begins a slow process of low-level chronic inflammation (macrophages, lymphocytes, etc.) which increases local release of TNF-α and IL-6[166]. TNF-α and IL-6 levels are inversely related with peripheral and hepatic glucose-uptake which is insulin-mediated[283]. The liver keeps excess uptake of FFA in serum to capacity by joining with glycerol (TAG) and slowly fatty liver is developed (NAFLD). It has been shown that peripheral fatty acids contribute approximately 60% of total TAG stored in the liver, whereas the novo lipogenesis in the liver is approximately 26% and approximately 15% is from the diet[284]. On the other hand, leptin levels respond directly to adipose expansion, while adiponectin levels tend to decrease when metabolic syndrome is developed. The elevated leptin levels should increase lipolysis in non-adipose tissues, decreasing excess fatty acids in these cells. However, this action of leptin may be partially blocked by the anabolic effect established by hyperinsulinemia, settling down leptin system dysfunction (peripheral leptin resistance)[115]. In addition, the decreased adiponectin levels are inversely related to peripheral glucose uptake and directly related with progressive development of chronic liver disease by fat infiltration. Adiponectin exerts a protective action on liver fat accumulation, favoring lipolysis by promoting the action of CPT-1, while interfering with the action of FAS, ACO and TNF-α, and decreasing the expression and action of CD-36 protein that promotes the transport of fatty acids[129]. Finally, both leptin and adiponectin seem to regulate the deposition of fat in insulin-sensitive tissues by increasing fat oxidation. IFN-γ: Interferon-γ; TNF-α: Tumor necrosis factor-α; IL: Interleukin; PPAR-γ: Peroxisome proliferator-activated receptor-γ; WAT: White adipose tissue; FFA: Free fatty acids; NAFLD: Non alcoholic fatty liver disease; CPT-1: Carnitine palmitoyltransferase-1; FAS: Fatty acid synthase; ACO: Acyl CoA carboxylase.
Figure 2 Dysfunctional adipose tissue. Early central obesity is associated with a low-grade chronic inflammatory state characterized by slow infiltration of macrophages which are an important source of inflammation of this adipose tissue[275,276]. Several macrophage subtypes can be found, and simply put, are divided in pro-inflammatory M1 or alternatively activated M2, although in vivo studies reveal a spectrum of macrophage phenotypes[277]. Adipocytes and immune cells such as T cells and macrophages participate in the activation and production of inflammatory cytokines[170,275,278,279]. The M1 macrophages mainly found in obesity, are induced from precursor M0 macrophages by stimulation of components of bacteria (lipopolysaccharide) and type 1 T-helper (Th1) inflammatory cytokines like IFN-γ and TNF-α. The M2 macrophages are activated by type 2 (Th2) cytokines such as IL-4 and IL-13. The M2 macrophages are abundant in adipose tissue of lean subjects and appear to be involved in remodeling, tissue repair, and maintenance of insulin sensitivity through the production and expression of IL-10, IL-1 receptor antagonist, and arginase-1. Whereas M1 macrophages use glucose for energy, M2 macrophages activate the β-oxidation of fatty acids[277,280]. Finally, M1 macrophages are the major source of inflammatory cytokines including TNF-α which inhibits adipose cell differentiation by activating Wnt signaling and suppressing expression of PPAR-γ transcription factor essential for the development and function of adipocyte, and reducing the effect on stored triglycerides[281,282]. The subcutaneous adipose tissue will continue to expand to an equilibrium point. When this capacity is exceeded, glucose and lipid uptake begins to decline and insulin levels are raised to maintain serum glucose in the normal range[215]. In addition, when WAT is unable to expand (inflexibility), associated with insulin resistance state, a continuous release of FFA to interstice begins, generating a systemic lipotoxic effect in muscle, liver, etc., (lipotoxicity). The adipose tissue itself begins a slow process of low-level chronic inflammation (macrophages, lymphocytes, etc.) which increases local release of TNF-α and IL-6[166]. TNF-α and IL-6 levels are inversely related with peripheral and hepatic glucose-uptake which is insulin-mediated[283]. The liver keeps excess uptake of FFA in serum to capacity by joining with glycerol (TAG) and slowly fatty liver is developed (NAFLD). It has been shown that peripheral fatty acids contribute approximately 60% of total TAG stored in the liver, whereas the novo lipogenesis in the liver is approximately 26% and approximately 15% is from the diet[284]. On the other hand, leptin levels respond directly to adipose expansion, while adiponectin levels tend to decrease when metabolic syndrome is developed. The elevated leptin levels should increase lipolysis in non-adipose tissues, decreasing excess fatty acids in these cells. However, this action of leptin may be partially blocked by the anabolic effect established by hyperinsulinemia, settling down leptin system dysfunction (peripheral leptin resistance)[115]. In addition, the decreased adiponectin levels are inversely related to peripheral glucose uptake and directly related with progressive development of chronic liver disease by fat infiltration. Adiponectin exerts a protective action on liver fat accumulation, favoring lipolysis by promoting the action of CPT-1, while interfering with the action of FAS, ACO and TNF-α, and decreasing the expression and action of CD-36 protein that promotes the transport of fatty acids[129]. Finally, both leptin and adiponectin seem to regulate the deposition of fat in insulin-sensitive tissues by increasing fat oxidation. IFN-γ: Interferon-γ; TNF-α: Tumor necrosis factor-α; IL: Interleukin; PPAR-γ: Peroxisome proliferator-activated receptor-γ; WAT: White adipose tissue; FFA: Free fatty acids; NAFLD: Non alcoholic fatty liver disease; CPT-1: Carnitine palmitoyltransferase-1; FAS: Fatty acid synthase; ACO: Acyl CoA carboxylase.CC BY-NC · PubMed Central
Figure 3 Adipose tissue expandability and metabolic syndrome. After a long period of overeating with positive energy balance, associated with increased hormones such as insulin, adipose tissue responds by increasing its storage capacity, which is determined by a number of factors. Individuals with a higher capacity for storing fat, mainly when peripheral WAT is expanded (WAT flexibility), most subjects will remain metabolically normal for a longer period, despite obesity developing. These subjects are observed to be metabolically healthy (MHO). Chronic inflammatory response leads to dysfunctional adipose tissue with increased local and endocrine secretion of acute phase reactants and inflammatory signaling pathways[285]. Abnormal cytokine and adipokines production is related to insulin resistance, hyperglycemia, altered lipid profile and cardiovascular diseases[115,286,287]. Insulin resistance slowly results from increased accumulation of lipids in other nonadipose tissues such as muscle (lipotoxicity) due to enhanced release of fatty acids from hypertrophic and hyperplasic adipocyte cells. In addition, when adipocytes achieve their maximal storage capacity, they begin to alter their adipokynes secretion profile. Therefore, a proinflammatory milieu with elevation in IL-6 and TNF-α and altered adipokines profile, with decreased adiponectin and increased leptin levels, with peripheral leptin resistance, in a dysfunctional adipose system is observed. This suggests that the limitation in storage capacity could be necessary and even precedes the development of metabolic factors. Ectopic lipid accumulation in non-adipocyte cells causes lipotoxicity in these organs and tissues, including inflammation and finally apoptosis. Thus, lipotoxicity in β-cell could decrease beta cell mass (dysfunction of β-cell secretion) and would cause diabetes. Increased fat in liver leads to hepatic steatosis (NAFLD) and steatohepatitis (NASH) and would cause hepatic dysfunction, in the heart would cause myocardiac dysfunction, in the endothelial fatty streak would be precursor of generalized arteriosclerosis, etc. At what point the adipose tissue begins to fail is likely to be determined by genetic and epigenetic factors. However, the question is: Can storage capacity in WAT be enhanced to meet an increased demand[288]? So far, in human trials, the PPAR-γ agonists (TZDs), that remove fat from central deposits toward more favorable peripheral deposits, have been shown to improve lipid profile, insulin-sensitivity, and reduce diabetes and NAFLD[269]. WAT: White adipose tissue; MHO: Metabolically healthy obese; IL: Interleukin; TNF-α: Tumor necrosis factor-α; NAFLD: Non alcoholic fatty liver disease; NASH: Nonalcoholic steatohepatitis; PPAR-γ: Peroxisome proliferator-activated receptor-γ; TZD: Thiazolidinedione.
Figure 3 Adipose tissue expandability and metabolic syndrome. After a long period of overeating with positive energy balance, associated with increased hormones such as insulin, adipose tissue responds by increasing its storage capacity, which is determined by a number of factors. Individuals with a higher capacity for storing fat, mainly when peripheral WAT is expanded (WAT flexibility), most subjects will remain metabolically normal for a longer period, despite obesity developing. These subjects are observed to be metabolically healthy (MHO). Chronic inflammatory response leads to dysfunctional adipose tissue with increased local and endocrine secretion of acute phase reactants and inflammatory signaling pathways[285]. Abnormal cytokine and adipokines production is related to insulin resistance, hyperglycemia, altered lipid profile and cardiovascular diseases[115,286,287]. Insulin resistance slowly results from increased accumulation of lipids in other nonadipose tissues such as muscle (lipotoxicity) due to enhanced release of fatty acids from hypertrophic and hyperplasic adipocyte cells. In addition, when adipocytes achieve their maximal storage capacity, they begin to alter their adipokynes secretion profile. Therefore, a proinflammatory milieu with elevation in IL-6 and TNF-α and altered adipokines profile, with decreased adiponectin and increased leptin levels, with peripheral leptin resistance, in a dysfunctional adipose system is observed. This suggests that the limitation in storage capacity could be necessary and even precedes the development of metabolic factors. Ectopic lipid accumulation in non-adipocyte cells causes lipotoxicity in these organs and tissues, including inflammation and finally apoptosis. Thus, lipotoxicity in β-cell could decrease beta cell mass (dysfunction of β-cell secretion) and would cause diabetes. Increased fat in liver leads to hepatic steatosis (NAFLD) and steatohepatitis (NASH) and would cause hepatic dysfunction, in the heart would cause myocardiac dysfunction, in the endothelial fatty streak would be precursor of generalized arteriosclerosis, etc. At what point the adipose tissue begins to fail is likely to be determined by genetic and epigenetic factors. However, the question is: Can storage capacity in WAT be enhanced to meet an increased demand[288]? So far, in human trials, the PPAR-γ agonists (TZDs), that remove fat from central deposits toward more favorable peripheral deposits, have been shown to improve lipid profile, insulin-sensitivity, and reduce diabetes and NAFLD[269]. WAT: White adipose tissue; MHO: Metabolically healthy obese; IL: Interleukin; TNF-α: Tumor necrosis factor-α; NAFLD: Non alcoholic fatty liver disease; NASH: Nonalcoholic steatohepatitis; PPAR-γ: Peroxisome proliferator-activated receptor-γ; TZD: Thiazolidinedione.CC BY-NC · PubMed Central
Figure 4 Insulin resistant syndrome and lipid metabolism. When obesity is developing, early abnormalities are observed at this time including hyperinsulinemia and low grade of proinflammatory state (↑ cytokines and PCR-hs), increase liberation of free fatty acids from adipose tissue (↑ lipolysis) and altered release of adipokines (↓ adiponectin, ↑leptin with leptin resistance). In some subjects, fatty liver develops later and consequently affects some functions of the liver. These include an early altered postprandial state (increasing glucose and triglyceride-rich VLDL particles), but finally these finding are observed in fasting state[289]. The VLDL particles undergo reduction by LPL and triglycerides are taken up by adipose tissue. The final result is the increase of cholesterol-rich small and dense LDL particles in serum. These LDL particles are highly susceptible to modifications like oxidation and glycation and the result is the increasing levels of ox-LDL, gly-LDL and the generation of antibodies to ox-LDL[190]. Finally, modified LDL are phagocytosed by macrophages in endothelial blood vessels and an inflammatory pattern that alters endothelial function initiating arteriosclerosis begins[177]. On the other hand, through ABC1 ligand the lipid efflux from peripheral cells to start the reverse transport of cholesterol is mediated. Mature HDL3 are generated from lipid-free apo A1 or lipid-poor pre-β1-HDL as the precursors, and LCAT-mediated sterification of cholesterol generates mature HDL3 and HDL2[189]. In T2D insulin-resistant patients, after adequate metabolic control the HDL3 cholesterol and APO A1 levels were increased. These findings were associated with a higher specific binding activity of HDL3 in those patients that showed improved insulin resistance[190]. Cholesterol efflux capacity has a strong inverse association with carotid intima-media thickness and was inversely associated with the incidence of cardiovascular events in a population-based cohort[188,290]. LCAT-mediated cholesterol esterification generates large spherical HDL2 particles, but large HDL2 can be converted in turn to small HDL3 upon CETP-mediated transfer of CE from HDL to apoB-containing lipoproteins, interfering with reverse cholesterol transport. Finally, SR-BI mediates the selective uptake of cholesteryl esters from HDL particles into mainly liver and steroidogenic organs[291]. VLDL: Very light density lipoprotein; LPL: Lipoprotein lipase; ox-LDL: Oxidized-LDL; gly-LDL: Glycated-LDL; ABC1: ATP-binding cassette transporter 1; LCAT: Lecithin cholesterol acyltransferase; CETP: Cholesteryl ester transfer protein; SR-BI: Scavenger receptor class-B, type I.
Figure 4 Insulin resistant syndrome and lipid metabolism. When obesity is developing, early abnormalities are observed at this time including hyperinsulinemia and low grade of proinflammatory state (↑ cytokines and PCR-hs), increase liberation of free fatty acids from adipose tissue (↑ lipolysis) and altered release of adipokines (↓ adiponectin, ↑leptin with leptin resistance). In some subjects, fatty liver develops later and consequently affects some functions of the liver. These include an early altered postprandial state (increasing glucose and triglyceride-rich VLDL particles), but finally these finding are observed in fasting state[289]. The VLDL particles undergo reduction by LPL and triglycerides are taken up by adipose tissue. The final result is the increase of cholesterol-rich small and dense LDL particles in serum. These LDL particles are highly susceptible to modifications like oxidation and glycation and the result is the increasing levels of ox-LDL, gly-LDL and the generation of antibodies to ox-LDL[190]. Finally, modified LDL are phagocytosed by macrophages in endothelial blood vessels and an inflammatory pattern that alters endothelial function initiating arteriosclerosis begins[177]. On the other hand, through ABC1 ligand the lipid efflux from peripheral cells to start the reverse transport of cholesterol is mediated. Mature HDL3 are generated from lipid-free apo A1 or lipid-poor pre-β1-HDL as the precursors, and LCAT-mediated sterification of cholesterol generates mature HDL3 and HDL2[189]. In T2D insulin-resistant patients, after adequate metabolic control the HDL3 cholesterol and APO A1 levels were increased. These findings were associated with a higher specific binding activity of HDL3 in those patients that showed improved insulin resistance[190]. Cholesterol efflux capacity has a strong inverse association with carotid intima-media thickness and was inversely associated with the incidence of cardiovascular events in a population-based cohort[188,290]. LCAT-mediated cholesterol esterification generates large spherical HDL2 particles, but large HDL2 can be converted in turn to small HDL3 upon CETP-mediated transfer of CE from HDL to apoB-containing lipoproteins, interfering with reverse cholesterol transport. Finally, SR-BI mediates the selective uptake of cholesteryl esters from HDL particles into mainly liver and steroidogenic organs[291]. VLDL: Very light density lipoprotein; LPL: Lipoprotein lipase; ox-LDL: Oxidized-LDL; gly-LDL: Glycated-LDL; ABC1: ATP-binding cassette transporter 1; LCAT: Lecithin cholesterol acyltransferase; CETP: Cholesteryl ester transfer protein; SR-BI: Scavenger receptor class-B, type I.CC BY-NC · PubMed Central
Figure 5 Mean (± SE) postprandial responses of insulin, proinsulin and glucagon-like peptide-1 levels (A), and glucose, triacylglycerol and high-density lipoprotein cholesterol levels (B), in 11 insulin-resistant subjects to three isocaloric (443 kcal) standard breakfasts. A breakfast rich in carbohydrates, a Mediterranean breakfast enriched with extra-virgin olive oil and standard breakfast high in saturated fat. The incremental AUC was calculated by the formula based on the trapezoid rule with adjustment for baseline concentrations. Repeated measures ANOVA and Tukey’s test. aP < 0.05; bP < 0.01[237]. CHO: High-carbohydrate; MUFA: Monounsaturated fatty acids; AUC: Area under the curve; ANOVA: Analysis of variance.
Figure 5 Mean (± SE) postprandial responses of insulin, proinsulin and glucagon-like peptide-1 levels (A), and glucose, triacylglycerol and high-density lipoprotein cholesterol levels (B), in 11 insulin-resistant subjects to three isocaloric (443 kcal) standard breakfasts. A breakfast rich in carbohydrates, a Mediterranean breakfast enriched with extra-virgin olive oil and standard breakfast high in saturated fat. The incremental AUC was calculated by the formula based on the trapezoid rule with adjustment for baseline concentrations. Repeated measures ANOVA and Tukey’s test. aP < 0.05; bP < 0.01[237]. CHO: High-carbohydrate; MUFA: Monounsaturated fatty acids; AUC: Area under the curve; ANOVA: Analysis of variance.CC BY-NC · PubMed Central
Figure 6 Prevalence of metabolic syndrome after 12-wk of diet assignment. HFSFA is a high fat diet rich in saturated fat and HFMUFA is a high fat diet rich in monounsaturated fat. LFHC-control is a low-fat, high complex carbohydrate diet and LFHC n-3 is a low-fat, high complex carbohydrate diet supplemented with 1.24 g/d of very long chain n-3 polyunsaturated fatty acid (VLC n-3 PUFA). χ2 test, P < 0.05)[261]. MetS: Metabolic syndrome; HFSFA: High fat diets rich in saturated fat; HFMUFA: High fat diets rich in monounsaturated fat; PUFA: Polyunsaturated fatty acids.
Figure 6 Prevalence of metabolic syndrome after 12-wk of diet assignment. HFSFA is a high fat diet rich in saturated fat and HFMUFA is a high fat diet rich in monounsaturated fat. LFHC-control is a low-fat, high complex carbohydrate diet and LFHC n-3 is a low-fat, high complex carbohydrate diet supplemented with 1.24 g/d of very long chain n-3 polyunsaturated fatty acid (VLC n-3 PUFA). χ2 test, P < 0.05)[261]. MetS: Metabolic syndrome; HFSFA: High fat diets rich in saturated fat; HFMUFA: High fat diets rich in monounsaturated fat; PUFA: Polyunsaturated fatty acids.CC BY-NC · PubMed Central

Verification

Claims the paper makes

131 Not checked yet · 18 Own interpretation · 17 No basis given · 5 Own result · 2 Own method

Verify all 191 references — free account

Show all 70 claims

  • It may state two separate claims as one. 74
  • Probably not a substantial claim. 51
103 of 103
  • The paper relies on this without support.

    High-carbohydrate rich diets increase postprandial peaks of insulin and glucose.

    “High-carbohydrate rich (CHO) diets increase postprandial peaks of insulin and glucose.”
  • The paper relies on this without support.

    Triglyceride-rich lipoproteins are increased by high-carbohydrate rich diets, which interferes with reverse cholesterol transport lowering HDL cholesterol.

    “Triglyceride-rich lipoproteins are also increased, which interferes with reverse cholesterol transport lowering high-density lipoprotein cholesterol.”
  • The paper relies on this without support.

    CHO-rich diets could move fat from peripheral to central deposits and reduce adiponectin activity in peripheral adipose tissue.

    “In addition, CHO-rich diets could move fat from peripheral to central deposits and reduce adiponectin activity in peripheral adipose tissue.”
  • The paper relies on this without support.

    MUFA-rich diets improve the effects of CHO-rich diets on postprandial insulin and glucose, triglyceride-rich lipoproteins, HDL cholesterol, fat distribution and adiponectin activity.

    “All these are improved with monounsaturated fatty acid-rich diets.”
  • The paper relies on this without support.

    Increased portions of ω-3 and ω-6 fatty acids decrease triglyceride levels.

    “Lastly, increased portions of ω-3 and ω-6 fatty acids also decrease triglyceride levels, and complement the healthy diet that is recommended in patients with MetS.”
  • The paper relies on this without support.

    The type of fat consumed could be more decisive than the total amount of fat consumed for changes in body composition and distribution of adipose tissue.

    “However, it is well established that the type of fat consumed could be more decisive than the total amount of fat consumed when we only look at changes in body composition and distribution of adipose tissue.”
  • The paper relies on this without support.

    Insulin resistance is a feature of MetS and is associated with other components of the syndrome.

    “In addition, insulin resistance is a feature of MetS and is associated with other components of the syndrome.”
  • The paper relies on this without support.

    The beneficial impact of fat quality on insulin sensitivity was not seen in individuals with a high fat intake (> 37E%).

    “The beneficial impact of fat quality on insulin sensitivity (IS) was not seen in individuals with a high fat intake (> 37E%).”
  • The paper relies on this without support.

    Glycemic load, excess fructose, and amount of dietary fiber influence various components of MetS.

    “Other dietary factors that can influence various components of MetS, like postprandial glycemic and insulin levels, triglycerides and high-density lipoprotein (HDL)-C levels, weight regulation and body composition, as well as fatty liver, are the glycemic load (GL) and the excess of fructose, and amount of dietary fiber content of food eaten.”
  • The paper relies on this without support.

    Increased levels of triglycerides associated with hypoalphalipoproteinemia are a feature of insulin resistance and MetS, and increase cardiovascular risk regardless of LDL cholesterol levels.

    “The increased levels of triglycerides associated with hypoalphalipoproteinemia are a feature of insulin resistance and MetS, and increase cardiovascular risk regardless of low-density lipoprotein (LDL) cholesterol levels.”
  • The paper relies on this without support.

    A higher intake of dietary fiber, particularly soluble type, above the level recommended by the ADA improves glycemic control, decreases hyperinsulinemia, and lowers plasma lipid concentrations in patients with type 2 diabetes.

    “However, more beneficial effects of a higher intake of dietary fiber, particularly of the soluble type, above the level recommended by the ADA, were reported to improve glycemic control, decreases hyperinsulinemia, and lower plasma lipid concentrations in patients with type 2 diabetes.”
  • The paper relies on this without support.

    The prevalence of enlarged waist circumference, hypertension and hypertriacylglycerolemia were reduced after the isoenergetic low fat high complex carbohydrates supplemented with ω-3 diet.

    “Lastly, the prevalence of enlarged waist circumference, hypertension and hypertriacylglycerolemia were reduced after the isoenergetic low fat high complex carbohydrates (LFHCC) supplemented with ω-3 diet.”
  • The paper relies on this without support.

    The prevalence of MetS fell by 20.5% after LFHCC ω-3 diet compared with the high saturated fatty acids (10.6%), high MUFA (12%) or LFHCC (10.4%) diets.

    “Thus, the prevalence of MetS fell by 20.5% after LFHCC ω-3 diet compared with the high saturated fatty acids (HSFA) (10.6%), high MUFA (HMUFA) (12%) or LFHCC (10.4%) diets.”
  • The paper relies on this without support.

    An equilibrate calory diet, low in animal fat, sugar and fructose, high in MUFA and PUFA, fresh vegetables high in fiber, and with moderate complex carbohydrates portions, could improve weight loss, lower postprandial glucose and insulin levels, and decrease triglyceride levels, and eventually increase HDL cholesterol.

    “In summary, an equilibrate calory diet, low in animal fat, sugar and fructose, high in MUFA and polyunsaturated fatty acids (PUFA), fresh vegetables high in fiber, and with moderate complex carbohydrates portions, could improve weight loss, lower postprandial glucose and insulin levels, and triglyceride levels could also decrease, and, eventually, increased HDL cholesterol levels are observed.”
  • The paper relies on this without support.

    Adipose tissue can expand to levels of inflexibility.

    “Adipose tissue could expand to levels of inflexibility.”
  • The paper relies on this without support.

    Most diets in the world provide enough ω-6 and too little ω-3, with an increased ratio ω-6:ω-3.

    “Today, most diets in the world provide enough ω-6 and too little ω-3, with an increased ratio ω-6:ω-3.”
  • The paper relies on this without support.

    At what point adipose tissue begins to fail is determined by genetic and epigenetic factors.

    “At what point the adipose tissue begins to fail is likely to be determined by genetic and epigenetic factors.”
  • The paper relies on this without support.

    The link between obesity and associated metabolic abnormalities is better related to the topography, anatomical distribution and/or functional peculiarities of adipose tissue, and this is more relevant in patients with relatively normal weight.

    “On top of all these factors, the link between obesity and associated metabolic abnormalities seems to be better related to the topography, anatomical distribution and/or the functional peculiarities of the adipose tissue, a phenomenon which seems to be more relevant in patients with relatively normal weight (Figures 2 and 3).”
  • The paper relies on this without support.

    Many men with insulin resistance, T2D or MetS present low testosterone concentrations with high or low gonadotropins (25% and 4%, respectively).

    “Finally, many men with insulin resistance, T2D or MetS present low testosterone concentrations with high or low gonadotropins (25% and 4%, respectively).”
  • The paper relies on this without support.

    Most patients with features of MetS have increased blood pressure.

    “Last, most patients with features of MetS have increased blood pressure.”
  • The paper relies on this without support.

    Central obesity and/or insulin resistance are the main causative requirements for metabolic syndrome.

    “While the pathogenesis of MetS and each of its components is complex, multifactorial and not well established, either central obesity and insulin resistance or both are recognized as the main causative requirements.”
  • The paper relies on this without support.

    Most components of metabolic syndrome are correlated with a sedentary lifestyle.

    “Most components of MetS are correlated with a sedentary lifestyle.”
  • The paper relies on this without support.

    Metabolic syndrome prevalence and each of its components is directly related with age in most people on the world.

    “MetS prevalence and each of its components is directly related with age in most people on the world.”
  • The paper relies on this without support.

    High saturated fat and sugar diets are implicated in the development of fatty liver.

    “Several mechanisms have implicated high SAT and sugar diets with the development of fatty liver.”
  • The paper relies on this without support.

    High oxidative stress is found in MetS patients, shown by raised activity of NADPH-oxidase and reduced expression of antioxidant enzymes in adipose tissue.

    “Moreover, a high oxidative stress is found in MetS patients, which is showed by a raised activity of NADPH-oxidase and a reduced expression of antioxidant enzymes in the adipose tissue.”
  • The paper relies on this without support.

    MetS patients normally present a higher inflammatory state in adipose tissue, which is increased during the postprandial response, independent of the fat eaten.

    “Last, MetS patients normally present higher inflammatory state in AT, which is increased during postprandial response, which was seen with independence of the fat eaten.”
  • The paper relies on this without support.

    ER stress is related to activation of inflammation and stress networks, closely linked to oxidative stress and insulin resistance.

    “ER stress has been related to many effects of disability cellular that include activation of inflammation and stress networks, closely linked to turn on with by oxidative stress and insulin resistance.”
  • The paper relies on this without support.

    Semi-skimmed milk and derivatives and eggs provide proteins of high biological value, provide some essential minerals, and are reasonably low in fat.

    “Both nutrients provide proteins of high biological value, provide some needs in essential minerals, and are reasonably low in fat.”
28 of 28

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

4 retracted

Show all 307 references

Research works printed but not linked: 3

  1. [2]Hill JO Pagliassotti MJ Peters JC Bouchard C Nongenetic determinants of obesity and fat topography. Genetic determinants of obesity 1994 Boca Raton, FL CRC Press 35 48
  2. [198]Stern MP LeRoith D Taylor SI Olefsky JM Impaired glucose tolerance: Risk factor or diagnostic category. Diabetes Mellitus. A Fundamental and Clinical Text 1996 Philadelphia Lippincott-Raven Publishers 467 474
  3. [285]Hotamisligil GS Inflammation, TNF-alpha and insulin resistance 2003 Philadelphia, PA, United States Lippincott-Raven Publishers

Cited by

Sorted by citations

See all 197

Metadata

Authors
Paniagua, J. A.
Affiliations
Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
Corresponding author
Paniagua, Juan Antonio
Venue
World Journal of Diabetes
Published
2016
Volume
7
Issue
19
Pages
483
ISSN
1948-9358 (ISSN-L)
OpenAlex
W2555771689
Cited by
197
References
307
Citations by year
2026: 7 · 2025: 24 · 2024: 17 · 2023: 13 · 2022: 31 · 2021: 15 · 2020: 24 · 2019: 23 · 2018: 25 · 2017: 18
FWCI
2.98
Type
journal article
Language
en
Open access
Locations
  • World Journal of Diabetes (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
metabolic syndrome, obesity, insulin resistance, abdominal obesity, abdominal fat, adipose tissue inflammation, adiponectin, leptin, hypertriglyceridemia, low HDL cholesterol, hepatic steatosis, high-carbohydrate diet, monounsaturated fatty acids, omega-3 fatty acids, omega-6 fatty acids, triglyceride-rich lipoproteins, reverse cholesterol transport, energy balance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review